RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Alertmeipp, That's right, the press release didn't say anything about dosing duration one way or the other, so we are left completely in the dark. We have no idea if we or a BP could even replicate the trial protocol of the successful ADHD Phase 2a. Can we do a 800 mg BID study for 3 weeks? Who knows. How about 500 mg BID for 3 weeks? Who knows. How about a 1000 mg once/day study for 3 weeks? Again, who knows. It's time for Dr. Stoll to shed some light on the situation.